Laboratory Medicine ›› 2019, Vol. 34 ›› Issue (3): 189-196.DOI: 10.3969/j.issn.1673-8640.2019.03.001
Clinical Mass Spectrometry Committee, Chinese Medical Doctor Association of Laboratory Medicine
Received:
2018-07-07
Online:
2019-03-30
Published:
2019-03-27
CLC Number:
Clinical Mass Spectrometry Committee, Chinese Medical Doctor Association of Laboratory Medicine. Consensus of method development and validation of liquid chromatography-tandem mass spectrometry in clinical laboratories[J]. Laboratory Medicine, 2019, 34(3): 189-196.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2019.03.001
乙醇基质 | 血清基质(提取后) | ||||
---|---|---|---|---|---|
样本名称 | 组分名称 | 峰面积 | 样本名称 | 组分名称 | 峰面积 |
Sample1-1 | D3-IS | 93 240 | Sample3-1 | D3-IS | 259 600 |
Sample1-1 | D3-IS | 97 270 | Sample3-1 | D3-IS | 272 200 |
Sample1-1 | D3-IS | 97 910 | Sample3-1 | D3-IS | 270 100 |
Sample1-2 | D3-IS | 111 300 | Sample3-2 | D3-IS | 260 900 |
Sample1-2 | D3-IS | 111 000 | Sample3-2 | D3-IS | 261 900 |
Sample1-2 | D3-IS | 112 500 | Sample3-2 | D3-IS | 262 300 |
Sample1-3 | D3-IS | 97 200 | Sample3-3 | D3-IS | 256 800 |
Sample1-3 | D3-IS | 99 710 | Sample3-3 | D3-IS | 273 500 |
Sample1-3 | D3-IS | 96 880 | Sample3-3 | D3-IS | 261 100 |
Sample1-4 | D3-IS | 105 500 | Sample3-4 | D3-IS | 274 100 |
Sample1-4 | D3-IS | 111 500 | Sample3-4 | D3-IS | 272 400 |
Sample1-4 | D3-IS | 111 200 | Sample3-4 | D3-IS | 278 100 |
Sample1-5 | D3-IS | 106 800 | Sample3-5 | D3-IS | 276 200 |
Sample1-5 | D3-IS | 106 700 | Sample3-5 | D3-IS | 278 600 |
Sample1-5 | D3-IS | 108 900 | Sample3-5 | D3-IS | 272 000 |
Sample1-6 | D3-IS | 114 100 | Sample3-6 | D3-IS | 270 100 |
Sample1-6 | D3-IS | 112 900 | Sample3-6 | D3-IS | 263 000 |
Sample1-6 | D3-IS | 113 300 | Sample3-6 | D3-IS | 268 800 |
均值 | 105 995 | 均值 | 268 428 | ||
CV(%) | 6.61 | CV(%) | 2.55 |
乙醇基质 | 血清基质(提取后) | ||||
---|---|---|---|---|---|
样本名称 | 组分名称 | 峰面积 | 样本名称 | 组分名称 | 峰面积 |
Sample1-1 | D3-IS | 93 240 | Sample3-1 | D3-IS | 259 600 |
Sample1-1 | D3-IS | 97 270 | Sample3-1 | D3-IS | 272 200 |
Sample1-1 | D3-IS | 97 910 | Sample3-1 | D3-IS | 270 100 |
Sample1-2 | D3-IS | 111 300 | Sample3-2 | D3-IS | 260 900 |
Sample1-2 | D3-IS | 111 000 | Sample3-2 | D3-IS | 261 900 |
Sample1-2 | D3-IS | 112 500 | Sample3-2 | D3-IS | 262 300 |
Sample1-3 | D3-IS | 97 200 | Sample3-3 | D3-IS | 256 800 |
Sample1-3 | D3-IS | 99 710 | Sample3-3 | D3-IS | 273 500 |
Sample1-3 | D3-IS | 96 880 | Sample3-3 | D3-IS | 261 100 |
Sample1-4 | D3-IS | 105 500 | Sample3-4 | D3-IS | 274 100 |
Sample1-4 | D3-IS | 111 500 | Sample3-4 | D3-IS | 272 400 |
Sample1-4 | D3-IS | 111 200 | Sample3-4 | D3-IS | 278 100 |
Sample1-5 | D3-IS | 106 800 | Sample3-5 | D3-IS | 276 200 |
Sample1-5 | D3-IS | 106 700 | Sample3-5 | D3-IS | 278 600 |
Sample1-5 | D3-IS | 108 900 | Sample3-5 | D3-IS | 272 000 |
Sample1-6 | D3-IS | 114 100 | Sample3-6 | D3-IS | 270 100 |
Sample1-6 | D3-IS | 112 900 | Sample3-6 | D3-IS | 263 000 |
Sample1-6 | D3-IS | 113 300 | Sample3-6 | D3-IS | 268 800 |
均值 | 105 995 | 均值 | 268 428 | ||
CV(%) | 6.61 | CV(%) | 2.55 |
样本 | 峰面积比值 | CV(%) | 偏差(%) | |||
---|---|---|---|---|---|---|
第1次测定 | 第2次测定 | 第3次测定 | 均值 | |||
乙醇基质 | 1.52 | 1.53 | 1.49 | 1.51 | 1.38 | 1.96 |
血清基质 | 0.53 | 0.52 | 0.53 | 0.53 | 1.10 | |
1:1混合物 | 1.01 | 1.01 | 0.97 | 1.00 | 2.32 |
样本 | 峰面积比值 | CV(%) | 偏差(%) | |||
---|---|---|---|---|---|---|
第1次测定 | 第2次测定 | 第3次测定 | 均值 | |||
乙醇基质 | 1.52 | 1.53 | 1.49 | 1.51 | 1.38 | 1.96 |
血清基质 | 0.53 | 0.52 | 0.53 | 0.53 | 1.10 | |
1:1混合物 | 1.01 | 1.01 | 0.97 | 1.00 | 2.32 |
样本 | 25(OH)D3 | L-L | H-L |
---|---|---|---|
L1 | 1.11 | ||
L2 | 1.13 | 1.13 | |
L3 | 1.09 | 1.09 | |
H1 | 52.80 | ||
H2 | 53.45 | ||
L4 | 1.16 | 1.16 | |
H3 | 53.60 | ||
H4 | 52.56 | ||
L5 | 1.10 | 1.10 | |
L6 | 1.14 | 1.14 | |
L7 | 1.09 | 1.09 | |
L8 | 1.05 | 1.05 | |
H5 | 52.28 | ||
H6 | 53.48 | ||
L9 | 1.09 | 1.09 | |
H7 | 52.14 | ||
H8 | 53.09 | ||
L10 | 1.15 | 1.15 | |
H9 | 52.79 | ||
H10 | 53.02 | ||
L11 | 1.12 | 1.12 | |
均值 | 1.10 | 1.12 | |
携带污染率(%) | -1.82 |
样本 | 25(OH)D3 | L-L | H-L |
---|---|---|---|
L1 | 1.11 | ||
L2 | 1.13 | 1.13 | |
L3 | 1.09 | 1.09 | |
H1 | 52.80 | ||
H2 | 53.45 | ||
L4 | 1.16 | 1.16 | |
H3 | 53.60 | ||
H4 | 52.56 | ||
L5 | 1.10 | 1.10 | |
L6 | 1.14 | 1.14 | |
L7 | 1.09 | 1.09 | |
L8 | 1.05 | 1.05 | |
H5 | 52.28 | ||
H6 | 53.48 | ||
L9 | 1.09 | 1.09 | |
H7 | 52.14 | ||
H8 | 53.09 | ||
L10 | 1.15 | 1.15 | |
H9 | 52.79 | ||
H10 | 53.02 | ||
L11 | 1.12 | 1.12 | |
均值 | 1.10 | 1.12 | |
携带污染率(%) | -1.82 |
样本名称 | 理论浓度 (ng/mL) | 样本数 | 测定均值 (ng/mL) | RSN | CV (%) | 偏移 (%) |
---|---|---|---|---|---|---|
样本1 | 0.50 | 15 | 0.65 | 5 | 17.61 | 30.00 |
样本2 | 1.25 | 15 | 1.41 | 26 | 13.94 | 12.80 |
样本3 | 2.50 | 15 | 2.71 | 47 | 9.33 | 8.40 |
样本名称 | 理论浓度 (ng/mL) | 样本数 | 测定均值 (ng/mL) | RSN | CV (%) | 偏移 (%) |
---|---|---|---|---|---|---|
样本1 | 0.50 | 15 | 0.65 | 5 | 17.61 | 30.00 |
样本2 | 1.25 | 15 | 1.41 | 26 | 13.94 | 12.80 |
样本3 | 2.50 | 15 | 2.71 | 47 | 9.33 | 8.40 |
样本 | 批次 | 均值(ng/mL) | 批内CV(%) | 批间CV(%) | 总CV(%) | 总均值(ng/mL) |
---|---|---|---|---|---|---|
低浓度 | 1 | 10.04 | 1.38 | 4.19 | 4.25 | 10.55 |
2 | 10.75 | 1.88 | ||||
3 | 10.85 | 2.11 | ||||
中浓度 | 1 | 16.51 | 2.08 | 2.23 | 3.44 | 16.29 |
2 | 15.87 | 2.40 | ||||
3 | 16.49 | 3.21 | ||||
高浓度 | 1 | 33.06 | 2.11 | 0.92 | 2.17 | 32.89 |
2 | 33.07 | 2.19 | ||||
3 | 32.54 | 1.16 |
样本 | 批次 | 均值(ng/mL) | 批内CV(%) | 批间CV(%) | 总CV(%) | 总均值(ng/mL) |
---|---|---|---|---|---|---|
低浓度 | 1 | 10.04 | 1.38 | 4.19 | 4.25 | 10.55 |
2 | 10.75 | 1.88 | ||||
3 | 10.85 | 2.11 | ||||
中浓度 | 1 | 16.51 | 2.08 | 2.23 | 3.44 | 16.29 |
2 | 15.87 | 2.40 | ||||
3 | 16.49 | 3.21 | ||||
高浓度 | 1 | 33.06 | 2.11 | 0.92 | 2.17 | 32.89 |
2 | 33.07 | 2.19 | ||||
3 | 32.54 | 1.16 |
样本编号 | 加标前 (ng) | 加入量(ng) | 测定量(ng) | 回收率(%) | 平均回收率(%) | CV(%) |
---|---|---|---|---|---|---|
1 | 4.05 | 5.01 | 5.01 | 100.00 | 99.40 | 0.53 |
4.03 | 5.03 | 4.99 | 99.20 | |||
4.06 | 5.00 | 4.95 | 99.00 | |||
2 | 4.09 | 10.22 | 10.39 | 101.66 | 100.22 | 1.22 |
4.09 | 10.33 | 10.29 | 99.61 | |||
4.09 | 10.19 | 10.14 | 99.51 | |||
3 | 4.04 | 20.09 | 20.12 | 100.15 | 99.92 | 0.25 |
4.08 | 20.05 | 19.98 | 99.65 | |||
4.05 | 20.11 | 20.10 | 99.95 |
样本编号 | 加标前 (ng) | 加入量(ng) | 测定量(ng) | 回收率(%) | 平均回收率(%) | CV(%) |
---|---|---|---|---|---|---|
1 | 4.05 | 5.01 | 5.01 | 100.00 | 99.40 | 0.53 |
4.03 | 5.03 | 4.99 | 99.20 | |||
4.06 | 5.00 | 4.95 | 99.00 | |||
2 | 4.09 | 10.22 | 10.39 | 101.66 | 100.22 | 1.22 |
4.09 | 10.33 | 10.29 | 99.61 | |||
4.09 | 10.19 | 10.14 | 99.51 | |||
3 | 4.04 | 20.09 | 20.12 | 100.15 | 99.92 | 0.25 |
4.08 | 20.05 | 19.98 | 99.65 | |||
4.05 | 20.11 | 20.10 | 99.95 |
[1] | Food and Drug Administration. Bioanalytical method validation guidance for industry[Z]. 2018. |
[2] | Clinical and Laboratory Standards Institute. Liquid chromatography-mass spectrometry methods[S]. C62-A,CLSI, 2014. |
[3] | Clinical and Laboratory Standards Institute. Mass spectrometry in the clinical laboratory:general principles and guidance[S]. C50-A,CLSI,2007. |
[4] | 中华医学会检验医学分会,卫生计生委临床检验中心. 液相色谱—质谱临床应用建议[J]. 中华检验医学杂志,2017,40(10):770-779. |
[5] | Clinical and Laboratory Standards Institute. Evaluation of precision of quantitative measurement procedures[S]. EP05-A3,CLSI,2014. |
[6] | 李水军,SIHE W.液相色谱-质谱联用技术临床应用[M]. 上海:上海科学技术出版社,2014:10. |
[7] | VOGESER M,SEGER C.Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory[J]. Clin Chem,2010,56(8):1234-1244. |
[8] | BOŽOVI A,KULASINGAM V. Quantitative mass spectrometry-based assay development and validation:from small molecules to proteins[J]. Clin Biochem,2013,46(6):444-455. |
[9] | VAN DEN OUWELAND J M,KEMA I P. The role of liquid chromatography-tandem mass spectrometry in the clinical laboratory[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2012,883-884:18-32. |
[10] | Scientific Working Group for Forensic Toxicology. Scientific Working Group for Forensic Toxicology(SWGTOX) standard practices for method validation in forensic toxicology[J]. J Anal Toxicol,2013,37(7):452-474. |
[11] | BONFIGLIO R,KING R C,OLAH T V,et al.The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds[J]. Rapid Commun Mass Spectrom,1999,13(12):1175-1185. |
[12] | TAYLOR P J.Matrix effects:the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry[J]. Clin Biochem,2005,38(4):328-334. |
[13] | EI-KHOURY J M,BUNCH D R,REINEKS E,et al. A simple and fast liquid chromatography-tandem mass spectrometry method for measurement of underivatized L-arginine,symmetric dimethylarginine,and asymmetric dimethylarginine and establishment of the reference ranges[J]. Anal Bioanal Chem,2012,402(2):771-779. |
[14] | International Organization for Standardization. Guide to the expression of uncertainty in measurement[S] .1995. |
[15] | European Chemical Measurement Traceability and Quality Improvement of Network Organization,Chemical Analysis of International Traceability Cooperation Group. Quantifying uncertainty in analytical measurement[S]. 2000. |
[1] | Expert Group on the Consensus on Androgen Testing in Polycystic Ovary Syndrome China Association for Promotion of Health Science and Technology-Fertility Protection and Preservation Committee. Consensus on androgen testing in polycystic ovary syndrome [J]. Laboratory Medicine, 2023, 38(3): 203-208. |
[2] | YANG Xiaodong, LI Quanle, PAN Qingqing, ZHOU Jing, XIE Yangmin, ZOU Jihua, SHEN Min, ZHANG Man. Establishment and performance evaluation of candidate reference measurement procedure for the determination of immunosuppressive drugs in human whole blood by ID-LC-MS/MS [J]. Laboratory Medicine, 2023, 38(3): 215-222. |
[3] | XU Runhao, ZOU Chen, CAO Yun, CHEN Feng, LIU Yijing, ZHANG Shulin, ZHANG Jie. Roles of serum amino acid determinations in the diagnosis of early non-small-cell lung cancer [J]. Laboratory Medicine, 2022, 37(12): 1157-1163. |
[4] | LI Bingling, CHENG Yating, ZHAO Beibei, SHE Xuhui, DONG Heng, YU Mujun. Evaluation of surrogate matrices for serum 25-hydroxyvitamin D calibrators by LC-MS/MS [J]. Laboratory Medicine, 2021, 36(2): 213-218. |
[5] | XU Runhao, ZOU Chen, ZHANG Jie, LI Min, ZHANG Shulin. Application of serum bile acid spectrum in the differential diagnosis of pneumonia and lung cancer [J]. Laboratory Medicine, 2021, 36(1): 1-7. |
[6] | ZOU Jihua, LI Quanle, SHEN Min, ZHANG Man, YANG Xiaodong, TU Minmin, FENG Dongfang, SUN Hongna. Establishment and performance evaluation of candidate reference measurement procedure for serum aldosterone by liquid chromatography-tandem mass spectrometry [J]. Laboratory Medicine, 2020, 35(8): 811-817. |
[7] | CAO Zheng, LIU Jingrui, XIE Xin, LIU Yilin, DONG Ying, TANG Guodong, ZHAI Yanhong. Determination of lecithin and sphingomyelin in amniotic fluid by ultra-performance liquid chromatography-tandem mass spectrometry [J]. Laboratory Medicine, 2020, 35(3): 233-237. |
[8] | LIU Jie, SHI Xinrong, ZHOU Shufen, XU Hongmin, ZHANG Lei, LIU Shuye. Serum metabolins predicting acute myocardial infarction patients' outcome [J]. Laboratory Medicine, 2019, 34(5): 383-389. |
[9] | ZHONG Qiaoling, SUN Ji, WENG Xuqi, FENG Ping, XIE Danyun. Accuracy evaluation of routine measurement procedure for serum homocysteine based on liquid chromatography-tandem mass spectrometry [J]. Laboratory Medicine, 2018, 33(8): 679-682. |
[10] | YUE Xiaojing, LI Wei, LI Pingfa. Determination of paraquat in plasma by HPLC-MS/MS [J]. Laboratory Medicine, 2018, 33(2): 132-138. |
[11] | YUAN Fengxi, XUE Xiongyan, CHEN Caifeng, LAI Yuehong, LIANG Yongyi, LI Yan, XIE Wenchun, YANG Shaojie, WU Yanjie. Influence of hemolysis on the results of plasma catecholamines and their metabolites by liquid chromatography-tandem mass spectrometry [J]. Laboratory Medicine, 2018, 33(12): 1103-1107. |
[12] | ZHAO Yinxia, OU Meixian, QU Yi, LU Youli, ZHANG Meiwei, LI Shuijun. Determination of human serum ouabain by UPLC-MS/MS and methodology comparison [J]. Laboratory Medicine, 2018, 33(11): 1013-1016. |
[13] | SHEN Min, YANG Xiaodong, WANG Lin, ZOU Jihua, ZHANG Man, ZOU Bingde. Establishment and performance evaluation of candidate reference measurement procedure for serum total homocysteine by liquid chromatography-tandem mass spectrometry [J]. Laboratory Medicine, 2018, 33(11): 1018-1025. |
[14] | WANG Kouqiong, SHAO Wenqi, PENG Yingfei, HUANG Fei, CHEN Fangjun, WU Jiong, WANG Beili, ZHANG Chunyan, GUO Wei, PAN Baishen. Establishment and performance evaluation of LC-MS/MS for the determination of plasma paclitaxel [J]. Laboratory Medicine, 2016, 31(5): 394-398. |
[15] | SONG Binbin, QIN Jiaqian, PENG Yingfei, ZHANG Chunyan, WU Jiong, WANG Beili, GUO Wei, PAN Baishen. Establishment on a LC-MS/MS and its performance characteristic evaluation for the determination of serum 25-hydroxyvitamin D [J]. Laboratory Medicine, 2015, 30(5): 416-420. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||